Association of the CTLA-4 gene with rheumatoid arthritis in Chinese Han population

European Journal of Human Genetics

Volumn 13, Issue 7, 2005, Pages 823-828

  Lei, Cai ^a   Dongqing, Zhang ^b   Yeqing, Shi ^c   Oaks, Martin K ^d   Lishan, Chen ^a   Jianzhong, Jin ^a   Jie, Qian ^a   Fang, Du ^b   Ningli, Li ^b   Xinghai, Han ^c   DaMing, Ren ^a  

^a FUDAN UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c SECOND MILITARY MEDICAL UNIVERSITY   (China)

^d ST LUKE S MEDICAL CENTER   (United States)

Author keywords

Cytotoxic T lymphocyte associated antigen 4; Denaturing gradient gel electrophoresis; Meta analysis; Rheumatoid arthritis

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GLYCINE;

ADULT; ALLELE; ARTICLE; ASIAN; CHINESE; CONTROLLED STUDY; DENATURING GRADIENT GEL ELECTROPHORESIS; EUROPE; FEMALE; GENE CONSTRUCT; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL SIGNIFICANCE;

3' UNTRANSLATED REGIONS; ADULT; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION; ARTHRITIS, RHEUMATOID; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHINA; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETICS, POPULATION; HAPLOTYPES; HUMANS; MALE; META-ANALYSIS; MIDDLE AGED; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 21744454152     PISSN: 10184813     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ejhg.5201423     Document Type: Article

References (34)

1. Jör JG, Cornelia MW: T-cell regulation in rheumatoid arthritis. Curr Opin Rheumatol 2004; 16: 121-217.
2. Kremer JM, Westhovens R, Leon M et al: Treatment of rheumatoid arthritis by selective inhibition of T-cell activation with fusion protein CTLA4Ig. N Engl J Med 2003; 349: 1907-1915.
3. Kouki T, Sawai Y, Gardine CA et al: CTLA-4 polymorphisms at position 49 in exon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of Graves' disease. J Immunol 2000; 165z: 6606-6611.
4. Marron MP, Zeidler A, Raffel LJ et al: Genetic and physical mapping of a type-1 diabeles susceptibility gene (IDDM12) to a 100-kb phagemid artificial chromosome clone containing D2S72-CTLA4-D2S105 on chromosome 2q33. Diabetes 2000; 49: 492-499.
5. Kantarci OH, Hebrink DD, Achenbach SJ et al: CTLA-4 is associated with susceptibility to multiple sclerosis. J. Neuroimmunol 2003; 134: 133-141.
6. Seidl C, Donner E, Fischer B, et al: CTLA4 codon 17 dimorphism in patients with iheumatoid arthritis. Tissue Antigens 1998; 51: 62-66.
7. Gonzalez-Escribano MF, Rodriguez R, Valenzuela A et al: CTLA-4 polymorphisms in Spanish patients with rheumatoid arthritis. Tissue Antigens 1999; 53: 296-300.
8. Yanagawa T, Gom K, Nakao EI et al: CTLA-4 gene polymorphism in Japanese patients with rheumatoid arthritis. J Rheumatol 2000; 27: 2740-2742.
9. Vaidya B, Pearce SH, Charlton S et al: An association between the CTLA-4 exon 1 polymorphism and early rheumatoid arthritis with autoimmune endocrinopathies. Rheumatology (Oxford) 2002; 41: 1213.
10. Barton A, Myerscough A, John S et al: A single nucleotide polymorphism in exon 1 of cytotoxic T-lymphocyte-associated-4 (CTLA-4) is not associated with rheumatoid arthritis. Rheumatology (Oxford) 2000; 39: 63-66.
11. Matsushita M, Tsuchiya N, Shiota M et al: Lack of a strong association of CTLA-4 exon polymorphism with the susceptibility to rheumatoid arthritis and systemic lupus erythematosus in Japanese: an association study using a novel variation screening method. Tissue Antigens 1999; 54: 578-584.
12. Lee YH, Choi SJ, Ji JD et al: No association of polymorphisms of the CTLA-4 exon 1(+49) and promoter (-318) genes with rheumatoid arthritis in the Korean population. Scand J Rheumatol 2002; 31: 266-270.
13. Ueda H, Joanna MM, Howson, Laura E et al: Association of the T-cell regulatory gene CTLA-4 with susceptibility to autoimmune disease. Nature 2003; 423: 506-511.
14. Arnett FC, Edworthy SM, Bloch DA: The American rheumatism association 1987 revised criteria for the classification of the rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-324.
15. Ying Wu, Hayes VW, Jan Osinga et al: Improvement of fragment and primer selection for mutation detection by denaturing gradient gel electrophoresis. Nucleic acids Res 1998; 26: 5432-5440.
16. Vanessa MH, Ying W, Jan O et al: Improvements in gel composition and electrophoretic conditions for broad-range mutation analysis by denaturing gradient gel electrophoresis. Nucleic acids Res 1999; 27: e29.
17. Tang G, Xie H, Xu L, Hao Y, Lin D, Ren D: Genetic study of apolipoprotein E gene, alpha-1 antichymotrypsin gene in sporadic parkinson disease. Am J Med Genet 2002; 114: 446-449.
18. Alex L, Mark PN, Richard MS et al: PyPop: a software framework for population genomics: analyzing large-scale multi-locus genotype data; in Altman R B, et al (eds):: Pacific Symposium on Biocomputing. Singapore: World Scientific, 2003, pp. 514-525.
19. Milicic A, Brown MA, Wordsworth BP: Polymorphism in codon 17 of the CTLA-4 gene (+49 A/G) is not associated with susceptibility to rheumatoid arthritis in British Caucasians. Tissue Antigens 2001; 58: 50-54.
20. Barton A, Jury F, Eyre S et al: Haplotype analysis in simples families and novel analytic approaches in a case-control cohort reveal no evidence of association of the CTLA-4 gene with rheumatoid arthritis. Arthritis Rheum 2004; 50: 748-752.
21. Lee CS, Lee YJ, Liu HF et al: Association of CTLA-4 gene A-G polymorphism with rheumatoid arthritis in Chinese. Clin Rheumatol 2003; 22: 221-224.
22. Liu MF, Wang CR, Chen PC, Lin TL: CTLA-4 gene polymorphism in promoter and exon-1 regions is not associated with Chinese patients with rheumatoid arthritis. Clin Rheumatol 2004; 23: 180-181.
23. Hadj KH, Kaddour N, Adyel FZ et al: HLA-DQB1 CAR1/CAR2, TNFa IR2/IR4 and CTLA-4 polymorphisms in Tunisian patients with rheumatoid arthritis and Sjgren's syndrome. Rheumatology 2001; 40: 1370-1374.
24. Krummel MF, Allison JP: CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells. J Exp Med 1996; 183: 2533-2540.
25. Lenschow DJ, Ho SC, Sattar H et al: Differential effects of anti-B7-1 and anti-B7-2mAb treatment on the development of diabetes in the NOD mouse. J Exp Med 1995a; 181: 1145-11SS.
26. Oaks MK, Hallett KM, Penwell RT et al: A native soluble form of CTLA-4. Cell Immunol 2000; 201: 144-153.
27. Oaks MK, Hallett KM: Cutting edge: a soluble form of CTLA-4 in patients with autoimmune thyroid disease. J Immunol 2000; 164: 5015-5018.
28. Sato S, Fujimoto M, Hasegawa M et al: Serum soluble CTLA-4 levels are increased in diffuse cutaneous systemic sclerosis. Rheumatology 2004; 43: 1261-1266.
29. Liu MF, Wang CR, Chen PC, Fung LL: Increased expression of soluble cytotoxic T-lymphocyte-associated antigen-4 molecule in patients with systemic lupus erythematosus. J Immunol 2003; 57: 568-572.
30. Becker N, Nieters A, Rittgen W: Single nucleotide polymorphism-disease relationships: statistical issues for the performance of association studies. Mutat Res 2003; 525: 11-18.
31. John PAI, Evangelia EN, Thomas AT: Racial. differences in genetic effects for complex diseases. Nat Genet 2004; 36: 1312-1318.
32. Van Belzen MJ, Mulder CJ, Zhernakova A et al: CTLA4 +49 A/G and CT60 polymorphisms in Dutch coeliac disease patients. Eur J Hum Genet 2004; 12: 782-785.
33. Torres B, Aguilar F, Franco E et al: Association of the CT60 marker of the CTLA4 gene with systemic lupus erythematosus. Arthritis Rheum 2004; 50: 2211-2215.
34. Maurer M, Loserth S, Kolb-Maurer A et al: Polymorphism in the human cytotoxic T-lymphocyte antigen 4 (CTLA4) gene (exon 1 +49) alters T-cell activation. Immunogenetics 2002; 54: 1-8.